ESTRADIOL

Chemical Identification
Chemical Identification
CAS # 50-28-2
Formula
 

C₁₈H₂₄O₂

Synonyms
 

β-estradiol; β-oestradiol; dihydrofolliculin; dihydoxyestrin; 1,3,5-estratriene-3,17 β-diol; 1,3,5(10)-triene-3,17-β-diol

Physical Properties
Physical Properties
Physical description White powder.
Boiling point Molecular weight 272.4
Freezing point/melting point 178-179°C Vapor pressure
Flash point Vapor density
Specific gravity Ionization potential
Lower explosive limit (LEL) Upper explosive limit (UEL)
NFPA health rating NFPA fire rating
NFPA reactivity rating NFPA special instruction
Vapor hazard ratio (VHR)
Historical exceedance percentage
Target organs
Monitoring Methods Used by OSHA
Monitoring Methods Used by OSHA
Analyte code (IMIS no.) E319
Sampling group
Sampler/Sampling media GFF Gelman Type A (37 mm) in 3-piece cassette no backup pad [SKC 225-706]
Sampling time*
 

240 min

Sampling volume (TWA)*
 

240 L

Sampling flow rate (TWA)*
 

1 L/min

Sampling volume (STEL/Peak/C)*
 

 

Sampling flow rate (STEL/Peak/C)*
 

 

Analytical method instruments HPLC
Method reference OSHA PV2001 (partially validated)
Notes
 

 

Special requirements
 

 

* All sampling instructions above are recommended guidelines for OSHA Compliance Safety and Health Officers (CSHOs), please see the corresponding OSHA method reference for complete details.

Wipe Method
Wipe Method
Sampler/Sampling media
 

 

Bulk Method
Bulk Method
 

 

On-Site Screening Techniques
On-Site Screening Techniques
Device
Model/Type
Sampling information
(see manufacturer instructions)
Exposure Limits
Exposure Limits
OSHA PEL
8-hour TWA
(ST) STEL
(C) Ceiling
Peak
NIOSH REL
Up to 10-hour TWA
(ST) STEL
(C) Ceiling
ACGIH TLV©
8-hour TWA
(ST) STEL
(C) Ceiling
CAL/OSHA PEL
8-hour TWA
(ST) STEL
(C) Ceiling
Peak
PEL-TWA
 

 

REL-TWA
 

 

TLV-TWA
 

 

PEL-TWA
 

 

PEL-STEL
 

 

REL-STEL
 

 

TLV-STEL
 

 

PEL-STEL
 

 

PEL-C
 

 

REL-C
 

 

TLV-C
 

 

PEL-C
 

 

Skin notation
 

NA

Skin notation
 

NA

Skin notation
 

NA

Skin notation
 

NA

Notes:
 

Not established

Notes:
 

Not established

Notes:
 

Not established

Notes:
 

Not established

Health factors:  See NIH-NLM PubChem. IDLH
Carcinogenic classifications: IARC-1, NTP Notes:
 

 

AIHA emergency response planning guidelines - ERPG-1/ERPG-2/ERPG-3:
 

 

Additional Resources and Literature References
Additional Resources and Literature References

NOAA: CAMEO Chemicals - Not listed

NIOSH: Pocket Guide to Chemical Hazards - Not listed

Literature References

 
  • No Author: Estrogens, Steroidal. Report on Carcinogens (latest edition); U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program.
  • National Institute for Occupational Safety and Health: NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings. NIOSH Publication No. 2004-165.
  • OSHA Technical Manual - Section VI: Chapter 2, Appendix VI: 2-1: Some Common Drugs Considered Hazardous.
  • Bélanger, A., et al.: Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J. Clin. Endocrinol. Metab. 79(4): 1086-1090, 1994.
  • de Ronde, W., Hofman, A., Pols, H.A.P. and de Jong, F.H.: A direct approach to the estimation of the origin of oestrogens and androgens in elderly men by comparison with hormone levels in postmenopausal women. Eur. J. Endocrinol. 152(2): 261-268, 2005.
  • Gruber, C.J., Tschugguel, W. Schneeberger, C. and Huber J.C.: Production and actions of estrogens. N. Engl. J. Med. 346(5): 340-352, 2002.
  • Kuiper, G.G.J.M., et al.: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138(3): 863-870, 1997.
  • Muller, M., den Tonkelaar, I., Thijssen, J.H., Grobbee, D.E. and van der Schouw, Y.T.: Endogenous sex hormones in men aged 40-80 years. Eur. J. Endocrinol. 149(6): 583-589, 2003.
  • Pohanish, R.P. (editor): Estradiol 17β. In, Sittig's Handbook of Toxic and Hazardous Chemicals and Carcinogens, Fourth Ed., Vol. 1. Norwich, NY: Noyes Publications, William Andrew Publishing, 2002, pp. 1023-1025.
  • Storgaard, L., Bonde, J.P. and Olsen, J.: Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of the published epidemiological studies. Reprod. Toxicol. 21(1): 4-15, 2006.
  • Uhler, M.L., Marks, J.W., Voigt, B.J. and Judd, H.L.: Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women. J. Clin. Endocrinol. Metab. 83(2): 410-414, 1998.

Last Updated Date : 12/28/2020